Theravance Biopharma to reduce board, cutting two long-term directors

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Theravance Biopharma Inc.

Theravance Biopharma, Inc. operates as a biopharmaceutical company. It focuses on the discovery, research, development, and commercialization of organ-selective medicines. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply